Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety trial of fluid-gel serum eye drops in dry eye disease
ISRCTN32614942Phase 2Terminated
- Sponsor
- University of Birmingham
- Start
- Apr 2025
- Modality
- Hydrogel Systems → Drug Delivery Systems
01
Overview
Phase 2, randomised, open-label trial of FLG-1001 and FLG-SED1 in dry eye syndrome (DED) and ocular surface disease (OSD), sponsored by University of Birmingham. Started Apr 2025; status: terminated.
02
Drugs
FLG-1001FLG-SED1
03
Conditions
dry eye syndrome (DED)ocular surface disease (OSD)
Beyond the preview
Go deeper on ISRCTN32614942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32614942.